Clinical Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2026

Key Benefits of the Report

This must-have industry resource provides exclusive insights to help companies assess, structure, and negotiate their own clinical-stage partnerships. Key benefits include:

✔ Unparalleled Market Insights – Gain a deep understanding of clinical-stage deal trends shaping the pharma and biotech industry since 2020.

✔ Exclusive Financial Data Access – Unlock headline values, upfront payments, milestone structures, and royalty terms, giving you a competitive edge in deal negotiations.

✔ Comprehensive Deal Database – Access a curated repository of 1,859 clinical-stage agreements, including contract documents where available, for unmatched transparency and benchmarking.

✔ Deep-Dive into Industry Leaders – Analyze actual clinical-stage deals entered into by the top 25 global pharma and biotech companies, alongside emerging biopharma players.

✔ Proven Case Studies & Structural Analysis – Examine real-world deal structures and case studies to refine your own partnering and negotiation strategies.

✔ High-Value Deal Identification – Pinpoint the most lucrative clinical-stage deals signed since 2020, gaining insight into premium industry transactions.

✔ Profile the Most Active Dealmakers – Identify the key players driving clinical-stage collaborations, ensuring you target the right partners.

✔ Strategic Deal Mapping – Navigate a full A-Z listing of clinical-stage agreements, categorized by company, development phase, deal type, therapeutic area, and technology focus.

✔ Negotiate with Confidence – Understand the key terms and conditions top-tier companies have agreed to in previous deals, helping you structure optimal agreements.

✔ Robust Due Diligence Support – Conduct data-backed assessments to determine the viability and competitiveness of your proposed deal terms with potential partners.

Executive Summary

 

Chapter 1 – Introduction

 

Chapter 2 – Why do companies partner clinical stage compounds?

 

2.1. Introduction

2.2. The role of clinical stage partnering

2.2.1. In-licensing at clinical stage

2.2.2. Out-licensing at clinical stage

2.3. Difference between phase I, II and III stage deals

2.4. Reasons for entering into clinical stage partnering deals

2.4.1. Licensors reasons for entering clinical stage deals

2.4.2. Licensees reasons for entering clinical stage deals

2.5. The future of clinical stage partnering deals

 

Chapter 3 – Clinical stage deal strategies and structure

 

3.1. Introduction

3.2. At what stage do companies partner?

3.2.1. Partnering early in pharmaceutical/biotech

3.2.1.1. Discovery and preclinical stage partnering case studies

3.2.1.1.a. Case study 1

3.2.1.1.b. Case study 2

3.2.1.1.c. Case study 3

3.2.1.1.d. Case study 4

3.2.2. Partnering later in pharmaceutical/biotech

3.2.2.1. Clinical stage partnering case studies

3.2.2.1.a. Case study 5

3.2.2.1.b. Case study 6

3.2.2.1.c. Case study 7

3.2.2.1.d. Case study 8

3.3. Early and later stage partnering – a risk/cost comparison

3.4. What do companies spend on clinical stage partnering?

3.5. Pure versus multi-component partnering deals

3.6. Pure licensing agreement structure

3.6.1. Example pure licensing agreements

3.6.1.a. Case study 9

3.6.1.b. Case study 10

3.7. Multicomponent clinical stage partnering agreements

3.7.1. Example multicomponent clinical stage clauses

3.7.1.a. Case study 11

 

Chapter 4 – Clinical stage partnering payment strategies

 

4.1. Introduction

4.2. Clinical stage payment strategies

4.3. Payment options

4.3.1. Headline values

4.3.2. Upfront payments

4.3.2.1. Conditionality of upfront payments

4.3.3. Loans

4.3.4. Convertible loans

4.3.5. Equity

4.3.6. R&D funding

4.3.7. Licensing fees

4.3.8. Milestone payments

4.3.9. Royalty payments

4.3.9.1. Issues affecting royalty rates

4.3.9.2. Royalties on combination products

4.3.9.2.a. Case study 12

4.3.9.3. Guaranteed minimum/maximum annual payments

4.3.9.4. Royalty stacking

4.3.9.5. Royalties and supply/purchase contracts

4.3.10. Quids

4.3.11. Option payments

 

Chapter 5 – Trends in clinical stage deal making

 

5.1. Introduction

5.2. Clinical stage partnering over the years

5.2.1. Trends in phase I deals since 2020

5.2.1.1. Attributes of phase I deals

5.2.2. Trends in phase II deals since 2020

5.2.2.2. Attributes of phase II deals

5.2.3. Trends in phase III deals since 2020

5.2.3.1. Attributes of phase III deals

5.3. Clinical stage partnering by deal type

5.4. Clinical stage partnering by disease type

5.5. Partnering by clinical stage technology type

5.6. Clinical stage partnering by most active company since 2020

 

Chapter 6 – Payment terms for clinical stage partnering

 

6.1. Introduction

6.2. Guidelines for clinical stage payment terms

6.2.1. Upfront payments

6.2.2. Milestone payments

6.2.3. Royalty payments

6.3. Clinical stage payment terms – deal data analysis

6.3.1. Public data

6.3.2. Survey data

6.4. Payment terms analysis

6.4.1. Clinical stage partnering headline values

6.4.2. Clinical stage deal upfront payments

6.4.3. Clinical stage deal milestone payments

6.4.4. Clinical stage royalty rates

6.5 Clinical stage median financials

6.5.1. Clinical stage headline value

6.5.2. Clinical stage upfront value

6.5.3. Clinical stage milestone value

6.5.4. Clinical stage royalty value

 

Chapter 7 – Leading clinical stage deals

 

7.1. Introduction

7.2. Top clinical stage deals by value

 

Chapter 8 – Top 25 most active clinical stage dealmakers

 

8.1. Introduction

8.2. Top 25 most active clinical stage dealmakers

 

Chapter 9 – Clinical stage partnering contracts directory

 

9.1. Introduction

9.2. Clinical stage deals with contracts since 2020

 

Chapter 10 – Clinical stage deal making by development stage

 

10.1. Introduction

10.2. Deals by clinical stage

Phase I

Phase II

Phase III

Regulatory

 

Appendices

 

Appendix 1 – Clinical stage dealmaking by companies A-Z

Appendix 2 – Clinical stage dealmaking by industry sector

Appendix 3 – Clinical stage dealmaking by stage of development

Appendix 4 – Clinical stage dealmaking by therapy area

Appendix 5 – Clinical stage dealmaking by technology type

 

About Biopharma Research Ltd

 

Current Partnering

Current Agreements

Recent report titles from Current Partnering

 

Table of figures

Figure 1: Definition of clinical phases in dealmaking

Figure 2: Components of the pure licensing deal structure

Figure 3: Payment options for clinical stage partnering deals

Figure 4: Issues affecting royalty rates

Figure 5: Clinical stage partnering by deal type

Figure 6: Clinical stage partnering by disease type

Figure 7: Clinical stage partnering by technology type

Figure 8: Top 25 most active clinical stage dealmakers

Figure 9: Review of upfront payments for clinical stage deals

Figure 10: Review of milestone payments for clinical stage deals

Figure 11: Review of royalty payments for clinical stage deals

Figure 12: Clinical stage deals with a headline value

Figure 13: Clinical stage deals with an upfront value

Figure 14: Clinical stage deals with a milestone value

Figure 15: Clinical stage deals with a royalty rate value

Figure 16: Top clinical stage deals by value

Figure 17: Most active clinical stage dealmakers

Pricing options

• $4,995: single-user
• $6,995: 2-5 users
• $8,995: Corporate (unencrypted PDF)

 

A full explanation of license type definitions can be found here.

 

Our guarantee

 

Latest report

If an update is published within 30 days of your purchase, you will receive it absolutely free of charge.

Serious Security

We take your data and security seriously. See our privacy policy for details of how we manage your data.

Sales Support

If you have any questions about your report, we will do our best to resolve your query. Contact us direct.

Total Trust

Current Partnering is a division of Biopharma Research Ltd., based in County Durham, United Kingdom. We have been trading successfully online since 2012 and work with some of the most famous brands in the business. We carefully select our partners to ensure that the publications meet expectations of demanding customers.

1cBio, 1ST Biotherapeutics, 2cureX, 3D Medicines, 3M, 3SBio, 4D Molecular Therapeutics, 4D Pharma, 4Living Biotech, 4P-Pharma, 4P Therapeutics, 4SC, 9 Meters Biopharma, Aadi Bioscience, AazeinTx, AB2 Bio, Abbisko Therapeutics, Abbvie, Abcam, ABEC, AbelZeta Pharma, Abeona Therapeutics, Abingworth Life Sciences, ABL Bio, ABLi Therapeutics, Abliva, ABVC BioPharma, ACADIA Pharmaceuticals, Acasti Pharma, Accro Bioscience, Acelrx Pharmaceuticals, Acelyrin, Acepodia, Acer Therapeutics, Achilles Therapeutics, Acibadem University, AC Immune, Aclaris Therapeutics, Aclipse Therapeutics, Acrivon Therapeutics, Actinium Pharmaceuticals, ActualEyes, Actuate Therapeutics, Acturum Life, Actym Therapeutics, Acumen Pharmaceuticals, Adagene, Adagio Therapeutics, Adamis Pharmaceuticals, Adaptimmune, Adaptive Phage Therapeutics, ADC Therapeutics, Addario Lung Cancer Medical Institute, ADEL, Adhera Therapeutics, Adial Pharmaceuticals, Adimune, Adiso Therapeutics, Adjuvance Technologies, Adlai Nortye, adMare BioInnovations, Advaccine Biotechnology, Advanced Regenerative Manufacturing Institute, Advanced Technology International, Advanz Pharma, Advaxis, Advent International, Adverum Biotechnologies, Aeglea BioTherapeutics, Aelix Therapeutics, Aerpio Pharmaceuticals, AffaMed Therapeutics, Affibody, Affimed Therapeutics, AFFiRiS, AGC Biologics, Agenus Bio, Agilent Technologies, Agility Life Sciences, Agios Pharmaceuticals, AgonOx, AIM ImmunoTech, AimMax Therapeutics, AiPharma Global Holdings, AirNexis Therapeutics, Ajinomoto Bio-Pharma Services, AJU Pharma, Akamis Bio, Akari Therapeutics, Akebia Therapeutics, Akeso Biopharma, AKL Research and Development, Akron Biotechnology, Akston Biosciences, Albany Molecular Research, Alchemab Therapeutics, Aldevron, Alector, Alesta Therapeutics, Alexion Pharmaceuticals, Alfasigma, Algernon Pharmaceuticals, Alida Biosciences, Aligos Therapeutics, Alkem Laboratories, Allarity Therapeutics, Allecra Therapeutics, Allegro Ophthalmics, Alligator Bioscience, Allist Pharma, Allogene Therapeutics, Allorion Therapeutics, Almac Group, Almirall, Alnylam Pharmaceuticals, Alopexx, Alphamab Biopharmaceuticals, Alphamab Oncology, Alpine Immune Sciences, Altasciences, Altimmune, Altum Pharmaceuticals, Alume Biosciences, Alumis, Alvogen, ALX Oncology, Alzamend Neuro, AlzeCure Pharma, Alzheimer's Drug Discovery Foundation, Alzheon, AM-Pharma, AmacaThera, Ambiopharm, Amgen, Amicus Therapeutics, AmMax Bio, Amneal Pharmaceuticals, AMO Pharma, Amphastar Pharmaceuticals, Amplyx Pharmaceuticals, Amylyx Pharmaceuticals, Amyndas Pharmaceuticals, Amytrx Therapeutics, AN2 Therapeutics, ANANDA Scientific, AnaptysBio, Andelyn Biosciences, Angelini Pharma, AnGes MG, Angion Biomedica, AnHeart Therapeutics, Ankyra Therapeutics, AnnJi Pharmaceutical, Annovis Bio, Antares Therapeutics, Antengene, Anteris Bio, Antibe Therapeutics, Antios Therapeutics, AOBiome Therapeutics, Apeiron Biologics, Apellis Pharmaceuticals, Apexian Pharmaceuticals, Apexigen, Aphex BioCleanse Systems, Apollomics, Apollo Therapeutics, Appili Therapeutics, Applied Biology, Applied Therapeutics, Aprea Therapeutics, AprilBio, Aptinyx, Aptose Biosciences, Aramis Biotechnologies, Aravive Biologics, Arbor Biotechnologies, Arbormentis, Arbutus, Arcellx, Archeus Technologies, Arch Oncology, Arctic Therapeutics, Arctic Vision, Arcturus Therapeutics, Arcus Biosciences, Arecor, Arecor Therapeutics, Arena Pharmaceuticals, Argo Biopharma, Ariana Pharma, Ariceum Therapeutics, Aridis Pharmaceuticals, ARISE MD Integrative Medicine & Surgery, Aristea Therapeutics, Armata Pharmaceuticals, ArriVent Biopharma, Arrowhead Pharmaceuticals, ARTBIO, Artelo Biosciences, Artiva Biotherapeutics, ARTMS Product, Aruvant Sciences, Arvinas, Asahi Kasei, Asarina Pharma, Asceneuron, Ascentage Pharma, Ascidian Therapeutics, Asher Bio, Asher Biotherapeutics, Ashion Analytics, Asieris MediTech, ASKA Pharmaceuticals, Aslan Pharma, Aspen Neuroscience, Assembly Biosciences, Association for Frontotemporal Degeneration, Astellas Pharma, Astellas Pharma US, Astex Pharmaceuticals, AstraZeneca, Astria Therapeutics, Asymchem Laboratories, Atara Biotherapeutics, Atea Pharmaceuticals, Athena Pharmaceutiques, Athira Pharma, ATMA Journey Centers, Atom Therapeutics, Atsena Therapeutics, aTyr Pharma, Auditus, AUM Biosciences, Aurobindo Pharma, Australian and New Zealand Children’s Haematology / Oncology Group, Autism Impact Fund, Autobahn Therapeutics, Autonomous Therapeutics, Avalo Therapeutics, Avance Clinical, Avania, Avecho Biotechnology, Avenue Therapeutics, Avenzo Therapeutics, AVEO Oncology, Aveta Biomics, AviadoBio, Avid Bioservices, AVM Biotechnology, Awakn Life Sciences, Axovant Gene Therapies, Axovia Therapeutics, Axsome Therapeutics, Ayala Pharmaceuticals, Azura Ophthalmics, AzurRx BioPharma, Bachem, Baili Biopharmaceutical, Baliopharm, Banner Alzheimer's Institute, Barbara Ann Karmanos Cancer Institute, Basilea Pharmaceutica, Battelle, Bausch Health Companies, Bavarian Nordic, Baxter International, Bayer, Baylor College of Medicine, BCM Europe, Beam Therapeutics, BeiGene, Beijing InnoCare Pharma, Beijing Tide Pharmaceutical, Belle.ai, Benuvia Therapeutics, BeOne Medicines, BerGenBio, Be The Match BioTherapies, BetterLife Pharma, Better Therapeutics, Beverly Hills Cancer Center, Beyond Cancer, Bharat Biotech, Bial, Bicycle Therapeutics, Bill and Melinda Gates Foundation, Binex, Bio-Techne, Bio-Thera Solutions, BioAge Labs, BioAtla, Biocept, BioCity Biopharma, Biocodex, Biocon, BioCorRx, BioCryst Pharmaceuticals, Biodesix, Biodexa Pharmaceuticals, Biodextris, BioEclipse Therapeutics, BioElpida, Biofabri, Bioforum, Biogen, Biohaven Pharmaceuticals, BioInvent, BioKey, Biolexis, BiolineRX, BioLink Life Sciences, Biological E, BioMarin Pharmaceutical, BioMatrix Specialty Pharmacy, Biomedical Advanced Research and Development Authority, BioMed Valley Discoveries, Biomerica, Biomica, Biomunex Pharmaceuticals, BiomX, Biond Biologics, Bioniz Therapeutics, BioNova Pharmaceuticals, BioNTech, BioPharma Services, bioRASI, BioRestorative Therapies, BioSenic, BioSight, Biosion, Biosplice, Biossil, Biotechnology Industry Research Assistance Council, Biotheus, BioVaxys, BioVectra, BioVersys, BioVie, BioXcel, BJ Bioscience, Black Diamond Therapeutics, Blackstone, Bliss Biopharmaceutical, Bluebird Bio, Blue Note Therapeutics, Blueprint Medicines, BNC Korea, Boehringer Ingelheim, Bold Therapeutics, Bolt Biotherapeutics, Bone Biologics, Bone Therapeutics, BOOST Pharma, BostonGene, Boston Immune Technologies and Therapeutics, Boston Pharmaceuticals, Botanix Pharmaceuticals, Boundless Bio, Bpifrance, Brainomix, Braintree Laboratories, Braveheart Bio, BriaCell Therapeutics, Brickell Biotech, BridgeBio Pharma, Bridge Biotherapeutics, Brigham and Women's Hospital, Bright Minds Biosciences, BrightPath Biotherapeutics, Brii Biosciences, Bristol-Myers Squibb, Brown University, BryoLogyx, Burning Rock, Butantan Institute, Byondis, C4 Therapeutics, Cabaletta Bio, Cadila Pharmaceuticals, Cadrenal Therapeutics, Caeregen Therapeutics, Calder Biosciences, Calian Group, Calico, Calidi Biotherapeutics, California Institute for Regenerative Medicine, Calithera Biosciences, Can-Fite BioPharma, Canadian Neuromuscular Disease Registry, CanariaBio, Cancer Focus Fund, Cancer Prevention and Research Institute of Texas, Cancer Research UK, Candel Therapeutics, Cantargia, Cantex Pharmaceuticals, Capricor Therapeutics, CARB-X, Cardiff Oncology, Cardinal Health, Care Access Research, Caris Life Sciences, Carisma Therapeutics, Carrick Therapeutics, CARsgen, CASI Pharmaceuticals, Cassava Sciences, Castle Creek Biosciences, Catabasis Pharmaceuticals, Catalent, Catalyst Clinical Research, Catalyst Pharmaceuticals, CCT Research, Ceapro, Cedar Clinical Research, Cedars-Sinai Medical Center, Celcuity, Celiac Disease Foundation, Cell and Gene Therapy Catapult, Cellares, Cell Cure Neurosciences, Cellectar Biosciences, Cellectis, Cellenkos, Cellino Biotech, Cellipont Bioservices, Cellistic, Cellular Biomedicine, CellVax Therapeutics, Celonic, Celyn Therapeutics, Cend Therapeutics, Center for Breakthrough Medicines, Centogene, Cerecor, CG Oncology, Charak Foundation, Charles River Laboratories, Checkmate Pharmaceuticals, Chemomab Therapeutics, Chengdu Kanghua Biological Products, Chi-Med, Chiesi Farmaceutici, Chimagen Biosciences, Chime Biologics, Chimeric Therapeutics, China Medical System, China Resources Sanjiu Medical and Pharmaceutical, Chipscreen NewWay Biosciences, Chong Kun Dang, Chongqing Yao Pharmaceutical, Chugai Pharmaceutical, CicloMed, Cidara Therapeutics, Cincinnati Children’s Hospital Medical Center, Circio, Circuit Clinical, CIRION BioPharma Research, City of Hope, Clarity Pharmaceuticals, ClearB Therapeutics, Clearmind Medicine, Cleave Therapeutics, Cleveland Clinic, Clinical Trial and Consulting Services, Clinica Universidad Navarra, Clinilabs, Clinlogix, Clover Biopharmaceuticals, Clovis Oncology, Cmed, CMG Pharmaceutical, CNS Pharmaceuticals, Coalition for Epidemic Preparedness Innovations, Cobra Biologics, Cocrystal Pharma, Codagenix, Codexis, Coeptis Pharmaceuticals, Coeptis Therapeutics, Cognition Therapeutics, Cognito Therapeutics, Coherus Biosciences, Columbia University, Combangio, Commonwealth of Pennsylvania, Compass Therapeutics, Compugen, Concentric Analgesics, Conduit Pharmaceuticals, Confo Therapeutics, Connect, ConSynance Therapeutics, Context Therapeutics, Contineum Therapeutics, ContraFect, Convergent Therapeutics, COPD Foundation, CORAT Therapeutics, Corbus Pharmaceuticals, CordenPharma, Corden Pharma, CoreRx Pharma, Cornell University, Corpometria Institute, Cortice Biosciences, CORXEL Pharmaceuticals, Cosmo Pharmaceuticals, COVAXX, Creapharm, Crescendo Biologics, Crescent Biopharma, Critical Path Institute (C-Path), Cromos Pharma, CryoPort, CSIR-Central Drug Research Institute, CSL, CSL Behring, CSPC Megalith Biopharmaceutical, CSPC Pharmaceutical Group, CS Pharmaceuticals, CStone Pharmaceuticals, Cue Biopharma, Cugene, Cullinan Oncology, Cullinan Therapeutics, Curasight, Curavit Clinical Research, CUREator, Curebase, Cure Stat Rx, Curetis, CureVac, Cureverse, Curis, Curium, Curon Biopharmaceutical, Curtana Pharmaceuticals, CyanVac, Cybin, Cybrexa Therapeutics, Cyclerion Therapeutics, Cyprium Therapeutics, Cyrano Therapeutics, Cystic Fibrosis Foundation, Cytiva, CytoAgents, Cytodyn, Cytokinetics, CytoSite Bio, Cytovance Biologics, Cytovation, D&D Pharmatech, Daewoong Pharmaceutical, Daiichi Sankyo, Dana-Farber Cancer Institute, Danish Cancer Society Research Center, Dare Bioscience, Day One Biopharmaceuticals, Debiopharm, Defender Pharmaceuticals, Defense Health Agency (US), Denovo Biopharma, Department of Defense, Department of Veterans Affairs, Dermapharm, Dermata Therapeutics, Dermavant Sciences, Develco Pharma, Deverra Therapeutics, Diaccurate, Diamond Therapeutics, Diamyd Medical, Dianthus Therapeutics, Dicerna Pharmaceuticals, Diffusion Pharmaceuticals, Dimerix Biosciences, Dispatch Bio, Diversigen, Dong-A ST, Dr. Falk Pharma, Dr. Reddy's Laboratories, Dragonfly Therapeutics, Dren Bio, DRI Capital, DRI Healthcare, Drug Farm, Drugs for Neglected Diseases Initiative, DSG, DualityBio, Duchenne UK, Duke-NUS Graduate Medical School Singapore, Duke Clinical Research Institute (DCRI), Duke University, Dutch Emotional Brain, DyDo Pharma, Dynacure, DynamiCure Biotechnology, Dynavax Technologies, DynPort Vaccine Company, Eagle Pharmaceuticals, EA Pharma, Eccogene, Eckert & Ziegler, Eczacıbasi-Monrol, Edith Wolfson Medical Center, eFFECTOR Therapeutics, Eiger BioPharmaceuticals, Eikonizo Therapeutics, Eikon Therapeutics, EIP Pharma, Eisai, Elanco, Eledon Pharmaceuticals, Elevar Therapeutics, ElevateBio, Elevation Oncology, Elicio Therapeutics, Eli Lilly, Elixirgen, Ellipses Pharma, Eloxx Pharmaceuticals, Elpiscience, Eluminex Biosciences, Emerald Innovations, Emergent BioSolutions, Emergex Vaccines, Emmes Group, Empirico, Emtora Biosciences, EmVenio Research, ENA Respiratory, ENCell, Endo International, Endpoint Health, ENDRA Life Sciences, Enlivex, Ensysce Biosciences, Entera Bio, Enterin, Enterome Bioscience, Entheon Biomedical, Entos Pharmaceuticals, Enveric Biosciences, Enzychem Lifesciences, EpicentRx, Epic Sciences, EQRx, Equillium, Equinox Science, Er-Kim, Erasca, Erasmus University Medical Center, ESSA Pharma, ES Therapeutics, Ethris, Eucure Biopharma, Eunice Kennedy Shriver Institute of Child Health and Human Development, Eureka Eurostars, Eurocine Vaccines, Eurofins Scientific, European Biomedical Research Institute of Salerno, European Commission, European Union, EUSA Pharma, Evaxion Biotech, Everest Medicines, Evergreen Theragnostics, Evergreen Therapeutics, EverInsight Therapeutics, Eversana, Evogene, Evolution Research Group, Evommune, Evopoint Biosciences, Evotec, Ewopharma, Excellmab, Excision BioTherapeutics, Exelixis, Exothera, Eyenovia, EyePoint Pharmaceuticals, F-Star Therapeutics, F4 Pharma, Factor Bioscience, Famy Life Sciences, Fareva Holding, FarmaMondo Group, Feinstein Institute for Medical Research, Ferrer, Ferring Pharmaceuticals, Fibrogen, Filament Health, Finch Therapeutics, Firefly Neuroscience, First Wave Bio, FivepHusion, Flare Therapeutics, Flatiron Health, Florence, Fluence, Food and Drug Administration (FDA), ForDoz Pharma, Foreseen Biotechnology, Foresee Pharmaceuticals, Forge Biologics, FORMA Therapeutics, Formation Bio, Formosa Pharmaceuticals, Formycon, Fortis Therapeutics, Fortrea, Fosun Pharmaceutical, Foundation Medicine, Fox Chase Cancer Center, Freeline Therapeutics, Fresh Tracks Therapeutics, Freya Pharma Solutions, Frontage Clinical Services, Frontier Biotech, Fujifilm, Fujifilm Diosynth Biotechnologies, Fuji Yakuhin, Fulcrum Therapeutics, Fusion Pharmaceuticals, FutureChem, G1 Therapeutics, G42 Healthcare, Gain Therapeutics, Galapagos, Galecto, Galera Therapeutics, Galimedix Therapeutics, Gamaleya National Center, GATC Health, Gates Medical Research Institute, GAVI Alliance, GC Pharma, GEICAM, Gemelli Teaching Hospital, Gemini Therapeutics, GEMMA Biotherapeutics, GEn1E Lifesciences, Genascence, Genelux, Genentech, Geneoscopy, Genethon, Genetika+, Genezen, Genfit, GenFleet Therapeutics, Genhouse Bio, Genome and Company, Genomind, Genosity, Genprex, Genrix Bio, Gensci, GenScript Biotech, GenScript ProBio, George Clinical, George Medicines, Georgetown University, George Washington University, Georgiamune, GeoVax, German Center for Infection Research, German Federal Ministry of Education and Research, German Government, Giiant Pharma, GI Innovation, Gilead Sciences, Gilgamesh Pharmaceuticals, Glaukos, Glenmark Pharmaceuticals, Glenmark Pharmaceuticals S.A., Global Coalition for Adaptive Research, Global Medical Solutions, Gloria Biosciences, GlycoMimetics, GlycoNex, Glycostem Therapeutics, Glycotope Biotechnology, GOG Foundation, Gore Range Capital, Gossamer Bio, Government of Canada, Government of France, Government of India, Government of Israel, Government of Netherlands, Government of Switzerland, GPCR Therapeutics, Granata Bio, Grand River Aseptic Manufacturing, Graviton Bioscience, Great Ormond Street Hospital (GOSH), Green Valley Pharmaceutical, Greenwich LifeSciences, Grey Wolf Therapeutics, Grifols, GRIN Therapeutics, Gritstone Bio, Groupe d'OncologieRadiothérapie Tête Et Cou, Groupe Francophone des Myélodysplasies, Grunenthal, GSK, GT Biopharma, GT Medical Technologies, Guangzhou Fermion Technology, Guardant Health, Gubra, Hadassah Medical Center, HaemaLogiX, Haisco Pharmaceutical, Halix, Halozyme Therapeutics, Halucenex Life Sciences, HanchorBio, Handok Pharmaceuticals, Hangzhou Highlightll Pharmaceutical, Hangzhou Zhongmei Huadong Pharmaceutical, Hanmi Pharmaceutical, Hansa Biopharma, Harbour Biomed, Harmony Biosciences, Harpoon Therapeutics, Harrow Health, Harvard Medical School, Hasten Biopharmaceutic, Haystack Oncology, HCW Biologics, Healis Therapeutics, Healthcare Royalty Partners, Health Hope Pharma, Healx, Helmholtz Zentrum Munchen, Helocyte, HELP Therapeutics, Helsinn Therapeutics, Hemispherian, Hemogenyx, Hengenix Biotech, Henlius Biotech, Hepalys Pharma, Hepion Pharmaceuticals, HepQuant, HiberCell, HIBio, HiFiBio, Highlight Therapeutics, Hikma Pharmaceuticals, HilleVax, Hillhurst Biopharmaceuticals, HistoIndex, HK inno.N, HMNC Brain Health, Hoffmann La Roche, Hookipa Pharma, Horizon Therapeutics, Hoth Therapeutics, Huadong Medicine, Hubble Therapeutics, Hubro Therapeutics, Humanigen, Hummingbird Bioscience, Hutchmed, Huyabio International, hVIVO, Hygieia, Hygtia Therapeutics, Hyloris Pharmaceuticals, Hypospray Pharma, I-mab, IACTA Pharmaceuticals, IAMA Therapeutics, Iambic Therapeutics, IBSA Group, Icahn School of Medicine at Mount Sinai, Ichnos Glenmark Innovation, Icon, IconOVir Bio, IDEAYA Biosciences, Idorsia, IDT Biologika, IGM Biosciences, Ikena Oncology, Iksuda Therapeutics, ILiAD Biotechnologies, Image Analysis, ImaginAb, Imeka, IMIDomics, Immedica, Immix Biopharma, ImmPACT Bio, Immune-Onc Therapeutics, Immuneering, ImmuneOnco Biopharmaceuticals, Immune Regulation, ImmuNext, Immunic, Immunicom, Immunis, ImmunityBio, ImmunoBrain Checkpoint, Immunocore, ImmunoForge, ImmunoGen, ImmunoGenesis, Immunome, Immunomedics, ImmunoPrecise Antibodies, Immusoft, Immutep, Immuthera, ImmVira, IMPACT-AML, IMPACT Therapeutics, Imperial College London, Imugene, IMV, InCarda Therapeutics, IncellDx, Incyclix Bio, Incyte, Indapta Therapeutics, InDex Pharmaceuticals, Indiana Biosciences Research Institute, iNGENu, Inivata, Inmagene Biopharmaceuticals, INmune Bio, Innolake Biopharm, Innosuisse, Innovare, Innovate UK, Innovative Cellular Therapeutics, Innovative Molecules, Innovent Biologics, Inotrem, Inovio, Inserm, Insilico Medicine, Inspirna, Instil Bio, Institut Bergonie, Institut Curie, Institute for Follicular Lymphoma Innovation, Institute of Cancer Research, Institute of Human Virology, Institute of Molecular Biology of Paraná (IBMP), Institut Gustave Roussy, Institut Pasteur, Intact Therapeutics, Intas Pharmaceuticals, IntelGenx, Intensity Therapeutics, International Vaccine Institute (IVI), Intract Pharma, Intrommune Therapeutics, Inventiva, InxMed, IO Biotech, Iolyx Therapeutics, iOnctura, Ionetix, Ionis Pharmaceuticals, Ionova, IPMC, Ipsen, IQVIA, IriSys, IRLAB, Ischemix, Isofol Medical, ISOThrive, Israeli National Authority for Technological Innovation, Italfarmaco, Italian Association for the Study of Pancreas, Italian Government, iTeos Therapeutics, Iterion Therapeutics, ITM Isotopen Technologien, iVeena Delivery Systems, Ixaka, IXICO, Jacobio Pharma, Jacobio Pharmaceuticals, Jaguar Health, JanOne, Janssen Biotech, Janssen Pharmaceuticals, Janssen Pharmaceutica NV, Janssen Research & Development, Janux Therapeutics, Japan Government, Japan Tobacco, Jasper Therapeutics, Jazz Pharmaceuticals, JCR Pharmaceuticals, jCyte, Jemincare, Jenner Institute, Jesse's Journey, Jiangsu Aosaikang Pharmaceutical, Jiangsu Hansoh Pharmaceutical, Jiangsu Hengrui Pharmaceuticals, Jiangsu QYuns Therapeutics, Jiangsu Wuzhong Pharmaceutical, Ji Xing Pharmaceuticals, JMT-Bio, Johns Hopkins University, Johnson & Johnson, Joincare Pharmaceutical, Journey Medical, Jumpcan Pharmaceutical, Juno Therapeutics, Junshi Biosciences, Juvenile Diabetes Research Foundation, JW Therapeutics, Kabuki Syndrome Foundation, Kaerus Bioscience, Kairos Pharma, Kaken Pharmaceutical, Kalbe Genexine Biologics, Kaleido Biosciences, KaliVir Immunotherapeutics, KalVista Pharmaceuticals, Kanazawa University, Kaneka, KARE Biosciences, Karis Bio, Karolinska Institute, Karuna Therapeutics, Karyopharm Therapeutics, Kashiv BioSciences, Kazia Therapeutics, KBP BioSciences, KdT Ventures, Keck School of Medicine of USC, Kelun-Biotech Biopharmaceutical, Kennedy Krieger Institute, Keros Therapeutics, Ketabon, KeyBioScience, Keymed Biosciences, Kezar Life Sciences, KGK Science, Kiadis Pharma, Kineta, Kiniksa Pharmaceuticals, Kinnate Biopharma, Kintor, Kiromic Biopharma, Kissei Pharmaceutical, Kite Pharma, Koneksa Health, Korea Drug Development Fund, Kowa, Krankenhaus Nordwest, KSQ Therapeutics, Kukbo, Kumquat Biosciences, Kura Oncology, KVK-Tech, Kwangdong Pharmaceutical, Kyorin Pharmaceutical, Kyowa Hakko Kirin, Kyowa Hakko Kogyo, Kyverna Therapeutics, LabConnect, Laboratoires Thea, Laboratorios Farmaceuticos Rovi, Laekna, LakePharma, Landos Biopharma, LaNova Medicines, Lantern Pharma, Lantheus Holding, Lantheus Medical Imaging, Launch Therapeutics, LaunXP Biomedical, Laurus Labs, Lava Therapeutics, Laxisam, Lee's Pharmaceutical, Lee Moffitt Cancer Center, Legend Biotech, LegoChem Biosciences, Lehigh Valley Health Network, Leiden University, Leios Therapeutics, LENZ Therapeutics, LEO Pharma, Lepu Biopharma, Les Laboratoires Servier, Leucid Bio, Leukemia & Lymphoma Society, Levolta Pharmaceuticals, LEXEO Therapeutics, Lexicon Pharmaceuticals, LG Chem, LianBio, LIB Therapeutics, LifeArc, Ligand Pharmaceuticals, LimmaTech Biologics, Lindis Biotech, Lineage Cell Therapeutics, Link Health, Link Immunotherapeutics, LinKinVax, Linnaeus Therapeutics, Lipidor, Lipomedix Pharmaceuticals, Lisata Therapeutics, Lixte Biotechnology, Longeveron, Lonza, LOTTE Biologics, Lotus Pharmaceuticals, Lucy Biotech, Lumos Pharma, Lundbeck, Lung Cancer Initiative, Lung Therapeutics, Lupus Therapeutics, Lyell Immunopharma, Lyndra Therapeutics, Lynk Pharmaceuticals, Lysogene, Lysosomal Therapeutics, Lytix Biopharma, Lyvgen Biopharma, Mabwell Bioscience, Macrogenics, Made Scientific, Madrigal Pharmaceuticals, Magenta Therapeutics, MAIA Biotechnology, Mapp Biopharmaceutical, Marker Therapeutics, Maruho, Massachusetts General Hospital, Massachusetts Institute of Technology, Mass General Brigham, Matrix Biomed, Matrix Medical Network, Maverick Therapeutics, Maxcyte, MaxiVAX, Mayo Clinic, Maze Therapeutics, McQuade Center for Strategic Research and Development, MD Anderson Cancer Center, Medac, Mediar Therapeutics, Medical Research Council, Medical Technology Enterprise Consortium, Medicenna Therapeutics, Medicines Development for Global Health, Medicines Patent Pool Foundation, MediciNova, Medidata Solutions, MediLink Therapeutics, Medivir, MediWound, Medsenic, MEI Pharma, Melinta Therapeutics, Melior Pharmaceuticals, Memorial Sloan Kettering Cancer Center, Menarini, Mendus, Merakris Therapeutics, Merck and Co, Merck KGaA, Merck Sharpe & Dohme, Mereo BioPharma, Merus, Mesoblast, ME Therapeutics, Metsera, Michael J Fox Foundation, Michigan Medicine, Microbion, Microbio Shanghai, Microbiotica, Micron Biomedical, MiMedx, Minaris Regenerative Medicine, MindMaze, Minerva Neurosciences, Minghui Pharmaceutical, Ministry of Health, Ministry of Health (Israel), Ministry of Health, Labor and Welfare, MiNK Therapeutics, Minoryx Therapeutics, Mirati Therapeutics, Mirror Biologics, Mirum Pharmaceuticals, MMS, Moderna, Moleculin Biotech, Molnlycke Health Care, Monopar Therapeutics, Monte Rosa Therapeutics, Montreal Heart Institute, MoonLake Immunotherapeutics, MorphoSys, Mosaic Therapeutics, MSD, MS Pharma, MThera Pharma, Multidisciplinary Association for Psychedelics Studies, Mustang Bio, Mydecine Group, Myovant Sciences, Myung In Pharm, Nacuity Pharmaceuticals, Nanjing Hanxin Pharmaceutical Technology, Nanjing Leads Biolabs, Nanobiotix, Nanoform, NanoMab Technology, Nantes University, NantKwest, NASA, Nascent Biotech, Natera, National Brain Tumor Society, National Cancer Center, National Cancer Institute, National Cheng Kung University, National Heart, Lung and Blood Institute, National Institute of Allergy and Infectious Diseases, National Institute of Child Health and Human Development, National Institute of Neurological Disorders and Stroke, National Institute on Aging, National Institute on Drug Abuse (NIDA), National Institutes of Health, National Research Council Canada, National Research Council of Canada, National University Cancer Institute, Navega Therapeutics, Naveris, Navitor Pharmaceuticals, NCK, NEC, Nectin Therapeutics, Nektar Therapeutics, Nelum Pharma, Neogenomics, NeoImmuneTech, Neoleukin Therapeutics, NeoLumina Bioscience, Nephron Pharmaceuticals, NervGen Pharma, Nestle Health Science, NETRIS Pharma, Neumentum, NeuraLight, Neurimmune Therapeutics, Neurizon Therapeutics, NeurMedix, NeuroBiogen, NeuroBo Pharmaceuticals, Neurocrine Biosciences, NeuroFront, Neurogastrx, NeuroGenesis, Neurolixis, Neurona Therapeutics, NeurOp, NeuroRx, NeuroSense Therapeutics, Neurotrope BioScience, NewAmsterdam Pharma, NewG Lab, New Hope Research Foundation, Newron Pharmaceuticals, Newsoara Biopharma, New York Cancer & Blood Specialists, New York University Langone Health, Nexcella, Neximmune, NextCure, NEXT Oncology, NFL Biosciences, NGM Biopharmaceuticals, Nicox, Nielsen BioSciences, NiKang Therapeutics, NImmune Biopharma, Nippon Shinyaku, NKGen Biotech, NKMax America, Nogra Pharma, Nordic Society of Gynaecological Oncology, NorthStar Medical Radioisotopes, Northway Biotechpharma, Northwell Health, Northwest Biotherapeutics, Northwestern University, Norwegian Cancer Society, Notable Labs, Nouscom, NovalGen, NovaQuest, Novaremed, Novartis, Novasep, Novatim Immune Therapeutics, Novavax, Novellus Biopharma, Novelty Nobility, Noveome Biotherapeutics, Novocure, Novogene, Novo Nordisk, Novotech, Now Biopharma, Noxopharm, NRx Pharmaceuticals, Nuance Pharma, Nucleus RadioPharma, Numab, Nuvation Bio, Nuvectis Pharma, Nuvisan Pharma Services, Nxera Pharma, Nykode Therapeutics, NYU Grossman School of Medicine for Preclinical and Clinical Research, NYU Langone Medical Center, Oak Hill Bio, Oasmia Pharmaceutical, OBI Pharma, Oblato, ObsEva, Octapharma, Ocugen, Ocuphire Pharma, Odeon Therapeutics, Olatec Therapeutics, Olema Oncology, Oligomerix, OliX Pharmaceuticals, Omeros, OmniaBio, OmniScience, Ona Therapeutics, Onco360, OncoC4, Oncoceutics, Oncoheroes Biosciences, OncoHost, OncoImmune, Oncologie, Oncology Venture, Oncolytics Biotech, OncoNano Medicine, OncoResponse, OncoSec Medical, OncoVent, OncoZenge, OncXerna Therapeutics, Oneness Biotech, OnKure, ONL Therapeutics, Ono Pharmaceutical, Onxeo, OpGen, OPKO Health, Optimi Health, Orano Med, Organon, Organovo, Orgenesis, ORIC Pharmaceuticals, Orient EuroPharma, Orion, Orsenix, OrsoBio, Orum Therapeutics, Oryzon, OSE Immunotherapeutics, Osel, Osivax, OS Therapies, Otsuka, Ottawa Health Research Institute, Ottawa Hospital Research Institute, Overland ADCT BioPharma, Overland Pharmaceuticals, Ovid Therapeutics, Owl Therapeutics, Oxford BioMedica, Oxford BioTherapeutics, Pacira Biosciences, Pacylex, Palisade Bio, Palleon Pharmaceuticals, Panbela Therapeutics, Panolos Bioscience, PanOptica, PanTher Therapeutics, Paragon Biosciences, Parexel, Parexel Biotech, Parkinson's UK, Parthenon Therapeutics, Partnership for Accelerating Cancer Therapies, Partner Therapeutics, Pascal Biosciences, Pasithea Therapeutics, Passage Bio, PathAI, Pathalys Pharma, Pathos AI, PaxMedica, PDS Biotechnology, PellePharm, Peptilogics, Percheron Therapeutics, Persephone Biosciences, Personalis, Peter MacCallum Cancer Institute, Pfizer, Phanes Therapeutics, Pharco Pharma, PharmAbcine, Pharmaceutical Solutions, PharmaLogic, Pharmanovia, Pharma Two B, PhaseBio Pharmaceuticals, Phathom Pharmaceuticals, Phebra, Phenex, Philochem, Philogen, Phio Pharmaceuticals, Phosplatin Therapeutics, Phost’in Therapeutics, Photys Therapeutics, PhysIQ, Pieris Pharmaceuticals, Pierre Fabre, Pinteon Therapeutics, Pionyr Immunotherapeutics, Piramal, Plexxikon, Pluristem Therapeutics, Plus Therapeutics, PlusVitech, PMV Pharma, PoC Capital, POINT Biopharma, Polaris Group, PoloMar Health, Polpharma, Polymed Biopharmaceuticals, Polyphor, Poolbeg Pharma, Population Health Research Institute, Portage Biotech, Poseida Therapeutics, PPD, Precirix, Precision BioSciences, Precision for Medicine, Prelude Therapeutics, Presage Biosciences, Prestige BioPharma, Prilenia Therapeutics, Prime Therapeutics, Primevera Therapeutics, Privo Technologies, Procare Health, Processa Pharmaceuticals, Progenetics, Progenics Pharmaceuticals, Project to Accelerate New Treatments for Tuberculosis, Prolium Bioscience, Prometheus Biosciences, Prometrika, Propella Therapeutics, ProQR Therapeutics, Protagonist Therapeutics, Prothena, Provention Bio, Providence, Providence Cancer Institute, Providence Therapeutics, PSI CRO, Psyence Biomedical, Psyence Group, Psyence Therapeutics, PT Bio Farma, PTC Therapeutics, Pulmokine, Pulmotect, Puma Biotechnology, PureTech Health, Purple Biotech, Q32 Bio, QBiotics, QED Therapeutics, QIAGEN, Qilu Pharmaceutical, QSAM Biosciences, Qualigen, QuantHealth, Quantum Leap Health Care Collaborative, Quartesian Clinical Research, Queensland Institute of Medical Research (QIMR), Quotient, QurAlis, Qurient, R-Pharm, Race Oncology, Radiance Biopharma, Radiomedix, Radiopharm Theranostics, Radius Health, Rain Oncology, Rakuten Medical, Rambam Medical Center, Rancho Santa Fe Bio, RAPT Therapeutics, Rasayana Therapeutics, Ratio Therapeutics, RayzeBio, Raziel Therapeutics, Re-Vana Therapeutics, ReAlta Life Sciences, Reata Pharmaceuticals, Recipharm, Recordati, RedHill Biopharma, Redx Pharma, RefleXion Medical, Regenerative Medicine of Latin America, Regeneron Pharmaceuticals, Regenexx, Regenxbio, Regio Biosciences, Regnum, Regor Therapeutics, Regulus Therapeutics, Relay Therapeutics, Relief Therapeutics, Relife, Relmada Therapeutics, RemeGen, Renexxion, Rentschler Biotechnologie, Repare Therapeutics, Replimune, ReproCell, Reset Pharmaceuticals, Res Nova Bio, Respira Therapeutics, Resverlogix, Resyca, Retinagenix, Revance Therapeutics, Reveal Genomics, ReveraGen BioPharma, reViral, Revive Therapeutics, Revolo Biotherapeutics, Revolution Medicines, Rgene, Rhizen Pharmaceuticals, Rho, Rhythm Pharmaceuticals, Ribomic, Ribon Therapeutics, Rigel Pharmaceuticals, Ripple Therapeutics, Rising Pharmaceuticals, Rivus Wellness and Research Institute, RLS, Roche, Rocket Pharmaceuticals, Roivant Sciences, Rokote Laboratories, Romanian National Institute of Infectious Diseases, RoslinCT, Roswell Park Cancer Institute, Royal Marsden Hospital, Royalty Pharma, RTW Investments, Rugen Therapeutics, Rune Labs, Russian Direct Investment Fund, Rutgers University, Rxilient Biotech, Ryvu Therapeutics, Rznomics, S.Biomedics, SAB Biotherapeutics, Salarius Pharmaceuticals, SAMIL Pharmiceuticals, Samsung Biologics, Sandoz, Saniona, Sanofi, SaNOtize Research and Development, Santen Pharmaceutical, Santhera Pharmaceuticals, Sapience Therapeutics, Sapu Bioscience, Sarah Cannon Research Institute, Sarepta Therapeutics, Savara Pharma, Scancell, Scandion Oncology, SciClone Pharmaceuticals, Science 37, Scilex Holding, Sciwind Biosciences, Scripps Research Institute, Seagen, Seattle Genetics, Sebela Pharmaceuticals, Second Genome, Secretome Therapeutics, Seikagaku, Selecta Biosciences, SELLAS Life Sciences Group, Sema4, Sen-Jam Pharmaceutical, Senhwa Biosciences, Senju Pharmaceutical, Sensei Biotherapeutics, Sentynl Therapeutics, Seoul National University, Sequel Med Tech, SERB Pharmaceuticals, Seres Therapeutics, Sermonix Pharmaceutical, Sernova, Serum Institute of India, Sesen Bio, Seven and Eight Biopharmaceuticals, SevenScore Pharmaceuticals, Seyltx, SFJ Pharmaceuticals, Shanghai Argo Biopharmaceutical, Shanghai ChemPartner, Shanghai Haini Pharmaceutical, Shanghai Lishan Biopharmaceuticals, Shanghai Public Health Clinical Centre, Sharp HealthCare, Shasqi, Shenzhen Chipscreen Biosciences, Shenzhen Kangtai Biological Products, Shenzhen Salubris Pharmaceuticals, Shionogi, Shirley Ryan AbilityLab, SIGA Technologies, Silexion Therapeutics, Silk Road Therapeutics, Simcere Pharmaceuticals, Simcere Zaiming, Simcha Therapeutics, Singlomics Biopharmaceuticals, Singota Solutions, SinoMab Bioscience, Sinopharm Group Beijing HuaHong, Sinovac Biotech, Sintetica, Sionna Therapeutics, Sirnaomics, SIRS Therapeutics, Sirtex Medical, SK Biopharmaceuticals, SK Bioscience, Skye Bioscience, SmartCella, Smerud Medical Research, Societal CDMO, Sol-Gel, Solasia Pharma, Solid Biosciences, Soligenix, Somite Therapeutics, Sonnet BioTherapeutics, Sorrento Therapeutics, Sorse Technology, Sosei, Sosei Heptares, SOTIO, Sparrow Pharmaceuticals, Specialised Therapeutics, SpectronRx, Spectrum Pharmaceuticals, Sperogenix Therapeutics, Spero Therapeutics, Spinogenix, Spring Bank Pharmaceuticals, SpringWorks Therapeutics, Spruce Biosciences, Stanford University, Stanford University School of Medicine, Starton Therapeutics, Statera Biopharma, St Elizabeth Healthcare, SteroTherapeutics, Stimunity, Stoke Therapeutics, Storm Therapeutics, Strados Labs, Strata Oncology, Streeterville Capital, Structure Therapeutics, Stuart Therapeutics, Sumitomo Pharma America, Sumitomo Pharmaceuticals, Summit Therapeutics, Sunovion Pharmaceuticals, Sun Pharmaceutical, Sunshine Lake Pharma, Sunstone Therapies, Supernus Pharmaceuticals, Supriya Lifescience, Surface Oncology, Sutro Biopharma, Suzhou Puhe BioPharma, Suzhou Ribo Life Sciences, Suzhou Sinovent Pharmaceuticals, Swedish Orphan Biovitrum, Swedish Research Council, Swing Therapeutics, Symbiosis, Synairgen, Synaptogenix, Syndax Pharmaceuticals, Syneos Health, Synhale Therapeutics, Synimmune, Synlogic, Synthekine, Syros Pharmaceuticals, Systimmune, T-Cure Bioscience, T-MAXIMUM Biotech, Tabuk Pharmaceutical, Tachyon Therapeutics, TaiGen Biotechnology, Taiho, Taiwan Bio Therapeutics, Takeda Pharmaceutical, Takeda Pharmaceuticals U.S.A, Tanner Pharma, TargetRx, Targovax, TargTex, Tarveda Therapeutics, Tasly Pharmaceuticals, Tavotek Biotherapeutics, TCR2 Therapeutics, Teitur Trophics, Telix Pharmaceuticals, Tempest Therapeutics, Tempus, Teon Therapeutics, Terns Pharmaceuticals, Terran Biosciences, TerSera Therapeutics, TerThera, Tessa Therapeutics, Teva Pharmaceutical Industries, Texcell, TFF Pharmaceuticals, Tharimmune, Thea Open Innovation, The Frontiers in Congenital Disorders of Glycosylation Consortium, The International AIDS Vaccine Initiative, Therabest, Theragent, Theramex, Theranexus, Therapeutic Solutions International, Theratechnologies, Theriva Biologics, Thermo Fisher Scientific, The United Laboratories, Third Arc Bio, Thomas Jefferson University, Tianjin CanSino Biotechnology, Tianjin JuveStar Biotech, TILT Biotherapeutics, TiumBio, Tivic Health Systems, Tiziana Life Sciences, Tolero Pharmaceuticals, TONIX Pharmaceuticals, Torii Pharmaceutical, TRACT Therapeutics, Transcenta, Transgene, TransThera, Travere Therapeutics, Treeway, Trethera, Trevena, TrialSpark, TRIGR Therapeutics, Trinity Pharmaceuticals, TriSalus Life Sciences, Triumvira Immunologics, TRPharm, Tryp Therapeutics, Tufts Medical Center, TuHURA Biosciences, Turning Point Therapeutics, TWi Biotechnology, TYG Oncology, Tyligand Bioscience, Tyme Technologies, UbiVac, UCB, UgeneX Therapeutics, UK Government, Ultragenyx Pharmaceuticals, UMass Memorial Medical Center, Undisclosed Company, Unicycive Therapeutics, UNION Therapeutics, UniQure, United BioPharma, UnitedHealth, University of Alabama at Birmingham, University of Alberta, University of Auckland, University of Birmingham, University of Calgary, University of California, Davis, University of California Los Angeles, University of Cambridge, University of Florida, University of Kansas, University of Michigan, University of Minnesota, University of Nebraska, University of North Carolina, University of Oxford, University of Pennsylvania, University of Pittsburgh Medical Center, University of Rochester, University of Rochester Medical Center, University of Sheffield, University of Sydney, University of Washington, University of Wisconsin, University of Wisconsin-Madison, Unlearn, Urica Therapeutics, UroGen Pharma, US Army Medical Research and Material Command, US Government, Usher Syndrome Coalition, US Oncology, Utrecht University, Vaccibody, Vaccinex, Vaccitech, Valneva, Valo Therapeutics, Vanda Pharmaceuticals, Vanderbilt University, Vaneltix Pharma, Vasomune Therapeutics, Vaxart, Vaximm, Vaxxinity, VBI Vaccines, VectivBio, Vedanta Biosciences, Veeva Systems, VenatoRx, Ventyx Biosciences, Veralox Therapeutics, Verastem, Vera Therapeutics, Verdiva Bio, Verge Genomics, Verily, VerImmune, Verismo Therapeutics, Verona Pharma, Verrica Pharmaceuticals, Veru, VGI Health Technology, Vial, Viatris, Vicore Pharma, Viewpoint Molecular Targeting, Vifor Pharma, Vigil Neuroscience, Viking Therapeutics, Vincera Pharma, Viracta Therapeutics, Vir Biotechnology, Virginia Catalyst, Viridian Therapeutics, VistaGen Therapeutics, Vitalli Bio, Vivet Therapeutics, Vividion Therapeutics, Vor Bio, vTv Therapeutics, Vyluma, Vyriad, Wacker Biotech, Wacker Chemie, Walgreens, Warpnine, WaVe Lifesciences, WAVE Life Sciences, Weill Cornell Medical College, Weizmann Institute, Wellcome Trust, Wellmarker Bio, Werewolf Therapeutics, Wigen Biomedicine, Windtree Therapeutics, Windward Bio, Winhealth Pharma Group, Wisconsin Alumni Research Foundation, Worldwide Clinical Trials, WPD Pharmaceuticals, WuXi Advanced Therapies, Wuxi Apptec Laboratory Services, WuXi Biologics, Wuxi STA, WuXi XDC, XBiotech, Xcellbio, Xencor, Xenetic Biosciences, Xenon Pharmaceuticals, Xequel Bio, Xiamen Amoytop Biotech, Xilio Therapeutics, Xlife Sciences, XNK Therapeutics, Xoma, Xortx Therapeutics, Xuanzhu Biopharma, XyloCor Therapeutics, Yale University, Yamo Pharmaceuticals, Yarrow Bioscience, Yeda Research and Development Company, Yingli Pharma, Yisheng Biopharma, Yumanity Therapeutics, Yunnan Walvax Biotech, ZAI Laboratory, Zambon, Zealand Pharma, Zedira, Zelgen, Zenas BioPharma, Zenith Epigenetics, Zentalis Pharmaceuticals, Zenyaku Kogyo, Zetagen Therapeutics, Zhaoke (Hong Kong) Ophthalmology Pharmaceutical, Zhejiang Doer Biotechnology, Zhittya Genesis Medicine, Zifo, Zion Medical, Zion Pharmaceuticals, Zura Bio, Zydus Cadila, Zydus Lifesciences, Zylo Therapeutics, Zymedi, Zymeworks, ZYUS Life Sciences, ZyVersa Therapeutics, ZZ Biotech

Current Partnering reports provide insight into the trends and terms of partnering deals in the global life sciences sector.

Current Partnering reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.

Current Partnering analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.

Current Partnering reports source deal data from our proprietary deals and alliances database, Current Agreements. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal. In addition, deal records are updated with new data as it becomes available.

The data in the Current Agreements deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.

Current Partnering provides comprehensive coverage of the following partnering or deal types:
• Asset purchase
• Assignment
• Co-development
• Co-market
• Co-promotion
• Collaborative R&D
• Contract service
• CRADA
• Cross-licensing
• Development
• Distribution
• Equity purchase
• Evaluation
• Grant
• Joint venture
• Licensing
• Loan
• Manufacturing
• Marketing
• Option
• Promotion
• Research
• Royalty financing
• Settlement
• Spin out
• Sub license
• Supply
• Termination
• Warrant

Every deal record is fully categorized and includes the following data, where available:
• Industry sector
• Therapy areas
• Technology type
• Deal components
• Financial terms
• Stage of development
• Exclusivity
• Asset type
• Geographic focus
• Excluded geography
• Company press release
• SEC filing data including contract document

All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.

Financial data and contract documents displayed in deal records is obtained from public sources, where disclosed by the parties to the deal.